BioSpace News Archive

Inspire Medical Systems, Inc. announced that its management team will present at the Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022 at the Lotte New York Palace Hotel in New York, NY.

Nkarta, Inc., a biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, announced its participation at three upcoming investor conferences.

BrainsWay Ltd. announced that it will report its third quarter financial results and operational highlights before the open of the U.S. financial markets on Wednesday, November 16, 2022.

Cullinan Oncology, Inc., a biopharmaceutical company focused on modality-agnostic targeted oncology for patients with cancer, announced that David P. Ryan, M.D. has been appointed to the company’s Board of Directors.

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) today announced that two poster presentations highlighting its lead drug candidate, rencofilstat, will be given at the Liver Meeting® 2022, to be hosted by the American Association for the Study of Liver Diseases (AASLD) November 4-8, 2022, in Washington, DC.

Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today reported corporate highlights and financial results for the third quarter of 2022.

Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development and commercialization of novel clinical-stage treatments for patients suffering from mental illnesses related to life-altering diseases, today announces that Lisa Deschamps, MBA has been appointed to the company’s Board of Directors.

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release third quarter 2022 financial results on Thursday, November 10th, prior to the market open.

Recursion, the clinical-stage biotechnology company industrializing drug discovery by decoding biology, announced its participation in the following November 2022 investor conferences.

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is inviting people across the country to take a “Moment for You” on Wednesday, November 16 and celebrate the biggest event of the year for BOTOX® Cosmetic.